股票
板块
用户
资讯
首页
天眼
自选
发现
开户
首页
天眼
自选
发现
我的

EDAN Makes First Appearance at ISUOG 2026 with Focus on Obst

LONDON, United Kingdom, 4 September 2026 – Edan Instruments, Inc. (300206.SZ), a global provider of medical devices and healthcare solutions, is making its first appearance at the ISUOG World Congress 2026, from 4 to 7 September at ExCeL London. As one of the most established academic platforms in obstetric and gynecological ultrasound, ISUOG brings together clinicians and EDAN has continued industry participants worldwide. At this congress, EDAN presents solutions shaped by its long-term engagement in women’s health, focusing on real-world clinical challenges and practical, integrated responses. “ISUOG represents a key forum for advancing clinical standards and innovation in obstetric ultrasound,” said Renfu Zhang, R&D Director of EDAN’s Ultrasound Division. “Over the years, to invest in the women’s health field, focusing on translating clinical needs into practical technologies. Our development aims to improve consistency and efficiency in everyday examinations, while supporting informed decision-making across different stages of care. Participating in ISUOG allows us to further align our innovation with evolving clinical practice.” This approach is reflected in EDAN Nano OB Assist, which addresses variability in fetal assessment through a structured scanning workflow. By guiding users through a defined process and automatically deriving key fetal parameters, it supports more standardized examinations, particularly in settings where consistency remains a challenge. Extending this focus into intrapartum care, the Acclarix GX9F series is designed for real-time evaluation during labor. It provides tools for assessing fetal position and labor progression, supporting more consistent and objective clinical assessment. Together, these solutions demonstrate how EDAN translates clinical insight into targeted innovation. Beyond individual products, the company presents a comprehensive obstetric portfolio covering ultrasound imaging, blood gas analysis, fetal and maternal monitoring, and pelvic floor rehabilitation. Combined with an integrated information system, this approach supports continuity of care from prenatal assessment to delivery. Guided by a commitment to improving the human condition, this integrated approach enables more consistent care across the clinical pathway. EDAN continues to develop accessible, reliable technologies supporting better outcomes and broader access to quality healthcare worldwide.
原文链接
多空观点 观点仅供交流,不构成投资建议
点赞
踩一踩
收藏
分享

评论 (0)

0/200
声明:社区内容仅代表用户个人观点,不构成任何投资建议。投资有风险,入市需谨慎。